Home › Funds › &PARTNERS › ABBV

&PARTNERS position in ABBV

ABBVIE INC · Health Care

&PARTNERS reported holding 448,801 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$114.3M, representing 0.42% of its reported portfolio and ranking #42 among its reported holdings. &PARTNERS has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)448.80K sh
Reported value held$114.35M
Portfolio Weight0.42%
First reportedQ3 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How &PARTNERS's ABBV position evolved

&PARTNERS first disclosed a stake in ABBV in Q3 2023 at 5,687 shares (US$848K). The position peaked in Q3 2026 at 448,801 shares, worth US$114.3M. Across 13 filings, &PARTNERS increased the stake 12 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 448,801 shares valued at US$114.3M — an increase of 23,118 shares quarter over quarter.. Notable position changes include a 79% increase in Q1 2024 (shares fell 5% over the following quarter), a 163% increase in Q2 2024 (shares rose 16% over the following quarter), a 206% increase in Q3 2024 (shares fell 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 5.69K $847.70K New
Q4 2023 8.24K $1.28M Add
Q1 2024 14.79K $2.69M Add
Q2 2024 38.96K $6.68M Add
Q3 2024 119.40K $23.53M Add
Q4 2024 208.73K $37.80M Add
Q1 2025 233.48K $47.94M Add
Q2 2025 284.21K $52.74M Add
Q3 2025 306.47K $66.43M Add
Q4 2025 382.48K $87.40M Add
Q1 2026 396.92K $86.27M Add
Q2 2026 425.68K $107.15M Add
Q3 2026 448.80K $114.35M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 32 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$38.97B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has &PARTNERS held ABBV?

&PARTNERS has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is &PARTNERS's current position in ABBV?

As of Q3 2026, &PARTNERS holds 448.80K shares of ABBV (ABBVIE INC), valued at $114.35M, representing 0.42% of its reported portfolio and ranking #42.

Has &PARTNERS been buying or selling ABBV?

In the latest 13F filing (Q3 2026), &PARTNERS increased its position in ABBV. The position peaked in Q3 2026 at 448.80K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.